There is increasing demand for advanced manufacturing technologies for fill-finish operations of parenteral drug products. To meet manufacturing requirements for multiple container and component types, flexible fill-finish equipment is at the forefront of most pharmaceutical, biotech, and CDMOs’ fill-finish strategy.
Flexible fill-finish technology is suitable for variable batch sizes allowing for scaling from clinical to commercial in multiple drug delivery presentations. With the ability to launch in vial configurations, prefilled syringes, or other combination products including devices, flexible fillers are beneficial to drug developers who are looking for lifecycle management of their drug products.
However, not all fill-finish original equipment manufacturers (OEM) are the same, and to ensure that an investment in flexible fill-finish equipment meets long-term needs, there are some critical aspects that need to be considered upfront.
In this article, explore some key considerations that need to be taken into account when selecting flexible fillers.